HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boots pre-close

This article was originally published in The Rose Sheet

Executive Summary

Boots Healthcare International second half sales jump about 13% at comparable exchange rates, UK company reports March 27 in a fiscal 2003 (ending March 31) 1pre-close statement. Clearasil sales continue to improve in response to increased marketing support and launches of new product lines, Boots states. Firm currently is rolling out Clearasil Total Control, a non-acne skin care line expected to generate $32 mil. in first year U.S. sales (2"The Rose Sheet" Dec. 16, 2002, p. 3). As part of company's increasing focus on core businesses, Boots the Chemists and Boots Healthcare International, Boots will exit Pure Beauty concept, which currently consists of six stores in the UK, firm says...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS011081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel